CCL5, CCR1 and CCR5 in murine glioblastoma: Immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5

Journal of Neuroimmunology

Volumn 246, Issue 1-2, 2012, Pages 10-17

  Pham, Kien ^a   Luo, Defang ^a   Liu, Che ^a   Harrison, Jeffrey K ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

GL261; Glioblastoma; Met CCL5; Microglia; RANTES

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL INFILTRATION; CONTROLLED STUDY; GENE DELETION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; WILD TYPE;

ANIMALS; BRAIN NEOPLASMS; CELL MOVEMENT; CELL SURVIVAL; CHEMOKINE CCL5; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMANS; MACROPHAGES; MICE; MICROGLIA; RECEPTORS, CCR1; RECEPTORS, CCR5;

EID: 84862832781     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.02.009     Document Type: Article

References (73)

1. Agarwal S., Sane R., Oberoi R., Ohfest J., Elmquist W. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain. Expert Rev. Mol. Med. 2011, 13:1-27.
2. Allen J., Crown E., Handel M. Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 2007, 25:787-820.
3. Alliot F., Godin I., Pessac B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Dev. Brain Res. 1999, 117:145-152.
4. Alterman R., Standley E. Colony stimulating factor-1 expression in human glioma. Mol. Chem. Neuropathol. 1994, 21:177-188.
5. Badie B., Schartner J. Role of microglia in glioma biology. Microsc. Res. Tech. 2001, 54:106-113.
6. Badie B., Schertner J., Klaver J., Vorpahl J. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth/scatter factor. Neurosurgery 1999, 44:1077-1082.
7. Badie B., Bartley B., Schartner J. Differential expression of MHC class II and B7 costimulatory molecules by microglia in rodent gliomas. J. Neuroimmunol. 2002, 133:39-45.
8. Bajetto A., Bonavia R., Barbero S., Schettini G. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochem. 2002, 82:1311-1329.
9. Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 2004, 4:540-550.
10. Bettinger I., Thanos S., Paulus W. Microglia promote glioma migration. Acta Neuropathol. 2002, 103:351-355.
11. Boehme S., Lio F., Maciejewski-Lenoir D., Bacon K., Conlon P. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J. Immunol. 2000, 165:397-403.
12. Chan W., Kohsaka S., Rezaie P. The origin and cell lineage of microglia: new concepts. Brain Res. Rev. 2007, 53:344-354.
13. Charles N., Holland E., Gilbertson R., Glass R., Kettenmann H. The brain tumor microenvironment. Glia 2011, 1180:1169-1180.
14. Davalos D., Grutzendler J., Yang G., Kim J., Zuo Y., Jung S., Littman D., Dustin M., Gan W. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8:752-758.
15. De Lemos C., Christensen J., Nansen A., Moos T., Lu B., Gerard, Christensen J., Thomsen A. Opposing effects of CXCR3 and CCR5 deficiency on CD8+ T cell-mediated inflammation in the central nervous system of virus-infected mice. J. Immunol. 2005, 175:1767-1775.
16. Fetler L., Amigorena S. Brain under surveillance: the microglia patrol. Science 2005, 309:392-393.
17. Flügel A., Labeur M., Grasbon-Frodl E., Kreutzberg G., Graeber M. Microglia only weakly present glioma antigen to cytotoxic T cells. Int. J. Dev. Neurosci. 1999, 17:547-556.
18. Furnari F., Huang H., Cavenee W. Genetics and malignant progression of human brain tumours. Cancer Surv. 1995, 25:233-275.
19. Gehrmann J., Matsumoto Y., Kreutzberg G. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Rev. 1995, 20:269-287.
20. Graeber M., Scheithauer B., Kreutzberg G. Microglia in brain tumors. Glia 2002, 40:252-259.
21. Harrison J., Luo D., Streit W. In situ hybridization analysis of chemokines and chemokine receptors in the central nervous system. Methods 2003, 29:312-318.
22. Holland E. Gliomagenesis: genetic alterations and mouse models. Nat. Rev. Genet. 2001, 2:120-129.
23. Hosli P., Sappino A., De Tribolet N., Dietrich P. Malignant glioma: should chemotherapy be overthrown by experimental treatments. Ann. Oncol. 1998, 9:589-600.
24. Hussain S., Yang D., Suki D., Aldape K., Grimm E., Heimberger A. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro-Oncology 2006, 8:261-279.
25. Iida N., Nakamoto Y., Baba T., Kakinoki K., Li Y., Wu Y., Matsushima K., Kaneko S., Mukaida N. Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner in mice. J. Leukoc. Biol. 2008, 84:1001-1010.
26. Kakinuma T., Hwang S. Chemokines, chemokine receptors, and cancer metastasis. Cancer 2006, 79:639-651.
27. Kelly K., Kirkwood J., Kapp D. Glioblastoma multiforme: pathology, natural history and treatment. Cancer Treat. Rev. 1984, 11:1-26.
28. Kielian T., Van Rooijen N., Hickey W. MCP-1 expression in CNS-1 astrocytoma cells: implications for macrophage infiltration into tumors in vivo. J. Neurooncol. 2002, 56:1-12.
29. Kleihues P., Soylemezoglu F., Schauble B., Burger P. Histopathology, classification, and grading of gliomas. Glia 1995, 15:211-221.
30. Koizumi K., Hojo S., Akashi T., Yasumoto K., Saiki I. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci. 2007, 98:1652-1658.
31. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N., Pastorino S., Purow B., Christopher N., Zhang W., Park J., Fine H. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9:391-403.
32. Leung S., Wong M., Chung L., Chan A., S.Y. Monocyte chemoattractant protein-1 expression and macrophage infiltration into gliomas. Acta Neurophathology 1997, 93.
33. Liang M., Mallari C., Rosser M., Ng H.P., May K., Monahan S., Bauman J.G., Islam I., Ghannam A., Buckman B., Shaw K., Wei G.P., Xu W., Zhao Z., Ho E., Shen J., Oanh H., Subramanyam B., Vergona R., Taub D., Dunning L., Harvey S., Snider R.M., Hesselgesser J., Morrissey M.M., Perez H.D. Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1. J. Biol. Chem. 2000, 275:19000-19008.
34. Liu C., Luo D., Streit W., Harrison J. CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes. J. Neuroimmunol. 2009, 198:98-105.
35. Liu C., Luo D., Reynolds B.A., Meher G., Katritzky A.R., Lu B., Gerard C.J., Bhadha C.P., Harrison J.K. Chemokine receptor CXCR3 promotes growth of glioma. Carcinogenesis 2011, 32:129-137.
36. Longden J., Cooke E., Hill S. Effect of CCR5 receptor antagonists on endocytosis of the human CCR5 receptor in CHO-K1 cells. Br. J. Pharmacol. 2008, 153:1513-1527.
37. Maeda K., Das D., Ogata-Aoki H., Nakata H., Miyakawa T., Tojo Y., Norman R., Takaoka Y., Ding J., Arnold G., Arnold E., Mitsuya H. Structural and molecular interactions of CCR5 inhibitors with CCR5. J. Biol. Chem. 2006, 281:12688-12698.
38. Mangiola A., Anike C., Pompucci A., Capone G., Rigante L., De Bonis P. Glioblastoma therapy: going beyond Hercules columns. Expert Rev. Neurotherapy 2010, 10:507-514.
39. Mantovani A., Savino B., Locati M., Zammataro L., Allavena P., Bonecchi R. The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev. 2010, 21:27-39.
40. Markovic D., Glass R., Synowitz M., Rooijen N., Kettenmann H. Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J. Neuropathol. Exp. Neurol. 2005, 64:754-762.
41. Markovic D., Vinnakota K., Chirasani S., Synowitz M., Raguet H., Stock K., Sliwa M., Lehmann S., Kälin R., Van Rooijen N., Holmbeck K., Heppner F.L., Kiwit J., Matyash V., Lehnardt S., Kaminska B., Glass R., Kettenmann H. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. PNAS 2009, 106:12530-12535.
42. Marks J. Radiation treatment of brain tumors: concepts and strategies. Crit. Rev.Neuroniology 1989, 5:93-112.
43. Morantz R., Wood G., Foster M., Clark M., Gollahon K. Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. J. Neurosurg. 1979, 50:305-311.
44. Morimura T., Neuchrist C., Kitz K., Budka H. Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation. Acta Neuropathol. 1990, 80:287-294.
45. Nakada M., Okada Y., Yamashita J. The role of matrix metalloproteinases in glioma invasion. Front. Biosci. 2003, 8:261-269.
46. Ni J., Zhu Y., Zhong X., Ding Y., Hou L., Tong X., Tang W., Ono S., Yang Y., Zuo J. The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function. Br. J. Pharmacol. 2009, 158:2046-2056.
47. Nicholas M., Lukas R., Chmura S., Yamini B., Lesniak M., Pytel P. Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges. Semin. Oncol. 2011, 38:243-253.
48. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
49. Nitta T., Sata K., Allegretta M., Brocke S., Lim M., Mitchell D., Steinman L. Expression of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor genes in human astrocytoma cell lines and in glioma specimens. Brain Res. 1992, 571.
50. Niwa Y., Akamatsu H., Niwa H., Sumi H., Ozaki Y., Abe A. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin. Cancer Res. 2001, 7:285-289.
51. Okada M., Saio M., Kito Y., Ohe N., Yano H., Yoshimura S., Iwama T., Takami T. Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1. Int. J. Oncol. 2009, 34:1621-1627.
52. Pellegatta S., Poliani P., Corno D., Menghi F., Ghielmetti F., Suarez-Merino B., Caldera V., Nava S., Ravanini M., Facchetti F., Bruzzone M., Finocchiaro G. Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res. 2006, 66:10247-10252.
53. Platten M., Kretz A., Naumann U., Aulwurm S., Egashira K., Isenmann S., Weller M. Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann. Neurol. 2003, 54:388-392.
54. Prados M. Biology and treatment of malignant glioma. Semin. Oncol. 2000, 27.
55. Proudfoot A., Power C., Hoogewerf A., Montjovent M., Borlat F., Offord R., Wells T. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J. Biol. Chem. 1996, 271:2599-2603.
56. Remick D., Green L., Newcomb D., Garg S., Bolgos G., Call D. CXC chemokine redundancy ensures local neutrophil recruitment during acute inflammation. Am. J. Pathol. 2001, 159:1149-1157.
57. Repeke C., Ferreira S., Claudino M., Silveira E., De Assis G., Avila-Campos M., Silva J., Garlet G. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice. Bone 2010, 46:1122-1130.
58. Rivest S. Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 2009, 9:429-439.
59. Robinson S., Scott K., Wilson J., Thompson R., Proudfoot A., Balkwill F. A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res. 2003, 63:8360-8365.
60. Roggendorf W., Strupp S., Paulus W. Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol. 1996, 92:288-293.
61. Rubin J., Kung A., Klein R., Chan J., Sun Y., Schmidt K., Kieran M., Luster A., Segal R. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. PNAS 2003, 100:13513-13518.
62. Saura J., Tusell J., Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia 2003, 44:183-189.
63. Sciumè G., Santoni A., Bernardini G. Chemokines and glioma: invasion and more. J. Neuroimmunol. 2010, 224:8-12.
64. Semple B., Kossmann T., Morganti-Kossmann M. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J. Cereb. Blood Flow Metab. 2010, 30:459-473.
65. Sliwa M., Markovic D., Gabrusiewicz K., Synowitz M., Glass R., Zawadzka M., Wesolowska A., Kettenmann H., Kaminska B. The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A. Brain 2007, 130:476-489.
66. Soria G., Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett. 2008, 267:271-285.
67. Stoll M., Capper D., Dietz K., Warth A., Schleich A., Schlaszus H., Meyermann R., Mittelbronn M. Differential microglial regulation in the human spinal cord under normal and pathological conditions. Neuropathol. Appl. Neurobiol. 2006, 32:650-661.
68. Streit W. Microglia and macrophages in the developing CNS. Neurotoxicology 2001, 22:619-624.
69. Tran C., Wolz P., Egensperger R., Kösel S., Imai Y., Bise K., Kohsaka S., Mehraein P., Graeber M. Differential expression of MHC class II molecules by microglia and neoplastic astroglia: relevance for the escape of astrocytoma cells from immune surveillance. Neuropathol. Appl. Neurobiol. 1998, 24:293-301.
70. Vaday G., Peehl D., Kadam P., Lawrence D. Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate 2006, 66:124-134.
71. Watters J., Schartner J., Badie B. Microglia function in brain tumors. J. Neurosci. Res. 2005, 81:447-455.
72. Yang I., Han S., Kaur G., Crane C., Parsa A. The role of microglia in central nervous system immunity and glioma immunology. J. Clin. Neurosci. 2010, 17:6-10.
73. Zhai H., Heppner F., Tsirka S. Microglia/macrophages promote glioma progression. Glia 2011, 59:472-485.